Accelus' Toro-L interbody fusion system was cleared by the FDA.
Toro-L is a biplanar expandable lateral implant with a minimal insertion profile, according to a May 19 news release. It has 3D-printed endplates and an inlet retractor.
"Toro-L was designed to offload the pressure on the innervated posterior psoas muscle without sacrificing footprint," Chris Walsh, Accelus CEO and co-founder, said in the release. "We strongly believe Toro-L will obviate many of the clinical challenges seen at the L4-L5 levels in the current lateral market.”